Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Were Hedge Funds Right About Corcept Therapeutics Incorporated (CORT)?
02:46am, Monday, 11'th May 2020
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the c
Corcept Therapeutics Shows Rising Price Performance With Jump To 85 RS Rating
10:27pm, Wednesday, 06'th May 2020
One stock that fits that bill is Corcept Therapeutics, which had its Relative Strength (RS) Rating upgraded from 77 to 85 Wednesday. Corcept Therapeutics is not currently offering a proper buying opp
Edited Transcript of CORT earnings conference call or presentation 4-May-20 9:00pm GMT
12:26am, Wednesday, 06'th May 2020
Q1 2020 Corcept Therapeutics Inc Earnings Call
Corcept Therapeutics Shows Rising Price Performance With Jump To 85 RS Rating
12:00am, Wednesday, 06'th May 2020Corcept (CORT) Q1 Earnings Top Estimates, Revenues Rise Y/Y
06:50pm, Tuesday, 05'th May 2020
Corcept's (CORT) earnings and revenues beat estimates in the first quarter of 2020. Solid adoption of the company's Cushing's syndrome drug, Korlym, drives sales.
New Strong Buy Stocks for May 5th
12:31pm, Tuesday, 05'th May 2020
New Strong Buy Stocks for May 5th
Corcept Therapeutics Incorporated (CORT) Q1 2020 Earnings Call Transcript
05:02am, Tuesday, 05'th May 2020
CORT earnings call for the period ending March 31, 2020.
Corcept (CORT) Q1 Earnings Top Estimates, Revenues Rise Y/Y
12:00am, Tuesday, 05'th May 2020Corcept Therapeutics (CORT) Tops Q1 Earnings and Revenue Estimates
11:05pm, Monday, 04'th May 2020
Corcept (CORT) delivered earnings and revenue surprises of 19.05% and 7.35%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Corcept Therapeutics Q1 EPS $0.340 Beats $0.220 Estimate, Sales $93.200M Beat $87.010M Estimate
08:18pm, Monday, 04'th May 2020Corcept Therapeutics Q1 Adj. EPS $0.340 Beats $0.220 Estimate, Sales $93.200M Beat $87.010M Estimate
08:14pm, Monday, 04'th May 2020Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update
08:05pm, Monday, 04'th May 2020
MENLO PARK, Calif. , May 04, 2020 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat.
Corcept Therapeutics (CORT) Tops Q1 Earnings and Revenue Estimates
12:00am, Monday, 04'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
